AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38
CD34 AUGMENTATION IMPROVES ALLOGENEIC T-CELL-DEPLETED BONE-MARROW ENGRAFTMENT
Authors: NOGA SJ SEBER A DAVIS JM BERENSON RJ VOGELSANG GB BRAINE HG HESS AD MARCELLUS D MILLER CA SHARKIS SJ GOODMAN SN SANTOS GW JONES RJ
Citation: Sj. Noga et al., CD34 AUGMENTATION IMPROVES ALLOGENEIC T-CELL-DEPLETED BONE-MARROW ENGRAFTMENT, Journal of hematotherapy, 7(2), 1998, pp. 151-157
CHEMOTHERAPY DOES NOT NULLIFY THE ABILITY OF DONOR LYMPHOCYTE INFUSIONS TO MEDIATE GRAFT-VERSUS-HOST REACTIONS
Authors: FUCHS EJ SEBER A ALTOMONTE V BRAINE HG HUMPHREY RL JONES RJ NOGA SJ SCHEPERS K WRIGHT SK VOGELSANG GB
Citation: Ej. Fuchs et al., CHEMOTHERAPY DOES NOT NULLIFY THE ABILITY OF DONOR LYMPHOCYTE INFUSIONS TO MEDIATE GRAFT-VERSUS-HOST REACTIONS, Bone marrow transplantation, 22(3), 1998, pp. 303-305
EXPANSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-CELLS (CTLS) IN GAS-PERMEABLE CELL-CULTURE BAGS
Authors: DAVIS JM LEMAS MV ORENTAS R EBY LL FABIAN D FLINN I NOGA SJ AMBINDER RF
Citation: Jm. Davis et al., EXPANSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-CELLS (CTLS) IN GAS-PERMEABLE CELL-CULTURE BAGS, Journal of acquired immune deficiency syndromes and human retrovirology, 14(4), 1997, pp. 127-127
ENGRAFTMENT FOLLOWING IN-UTERO BONE-MARROW TRANSPLANTATION FOR GLOBOID-CELL LEUKODYSTROPHY
Authors: BAMBACH BJ MOSER HW BLAKEMORE K CORSON VL GRIFFIN CA NOGA SJ PERLMAN EJ ZUCKERMAN R WENGER DA JONES RJ
Citation: Bj. Bambach et al., ENGRAFTMENT FOLLOWING IN-UTERO BONE-MARROW TRANSPLANTATION FOR GLOBOID-CELL LEUKODYSTROPHY, Bone marrow transplantation, 19(4), 1997, pp. 399-402
CD34(-CELL AUGMENTATION OF ALLOGENEIC, ELUTRIATED MARROW GRAFTS IMPROVES ENGRAFTMENT BUT CYCLOSPORINE-A IS STILL REQUIRED TO REDUCE GVHD AND MORBIDITY() STEM)
Authors: NOGA SJ VOGELSANG GB SEBER A DAVIS JM SCHEPERS K HESS AD JONES RJ
Citation: Sj. Noga et al., CD34(-CELL AUGMENTATION OF ALLOGENEIC, ELUTRIATED MARROW GRAFTS IMPROVES ENGRAFTMENT BUT CYCLOSPORINE-A IS STILL REQUIRED TO REDUCE GVHD AND MORBIDITY() STEM), Transplantation proceedings, 29(1-2), 1997, pp. 728-732
LARGE-SCALE EXPANSIONS OF EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTE (CTL) LINES LYSE EBV INFECTED HAPLOIDENTICAL TARGET-CELLS BUT NOT UNINFECTED AUTOLOGOUS OR HAPLOIDENTICAL CELLS
Authors: LEMAS MV DAVIS J EBY LL FABIAN D ORENTAS R FLINN I NOGA SJ AMBINDER R
Citation: Mv. Lemas et al., LARGE-SCALE EXPANSIONS OF EBV-SPECIFIC CYTOTOXIC T-LYMPHOCYTE (CTL) LINES LYSE EBV INFECTED HAPLOIDENTICAL TARGET-CELLS BUT NOT UNINFECTED AUTOLOGOUS OR HAPLOIDENTICAL CELLS, Blood, 90(10), 1997, pp. 590-590
USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MULTIPLE-MYELOMA (MM)
Authors: NOGA SJ ODONNELL PV GREVER M VOGELSANG GB MARCELLUS D JONES RJ
Citation: Sj. Noga et al., USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MULTIPLE-MYELOMA (MM), Blood, 90(10), 1997, pp. 992-992
USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MYELODYSPLASTIC SYNDROME (MDS)
Authors: ODONNELL PV NOGA SJ GREVER M VOGELSANG GB JONES RJ
Citation: Pv. Odonnell et al., USING ENGINEERED ALLOGRAFTS TO IMPROVE TRANSPLANT OUTCOME IN MYELODYSPLASTIC SYNDROME (MDS), Blood, 90(10), 1997, pp. 1009-1009
GM-CSF-MEDIATED DIFFERENTIATION THERAPY FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML)
Authors: JONES RJ GRIFFIN CA SMITH BD GLADSTONE DE NOGA SJ MILLER CB BEDI A
Citation: Rj. Jones et al., GM-CSF-MEDIATED DIFFERENTIATION THERAPY FOLLOWING BONE-MARROW TRANSPLANTATION (BMT) FOR CHRONIC MYELOID-LEUKEMIA (CML), Blood, 90(10), 1997, pp. 1035-1035
SIMILAR BREAST-CANCER CELL CONTAMINATION OF SINGLE-DAY PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS OBTAINED AFTER PRIMING WITH HEMATOPOIETIC GROWTH-FACTOR ALONE OR AFTER CYCLOPHOSPHAMIDE FOLLOWED BY GROWTH-FACTOR
Authors: PASSOSCOELHO JL ROSS AA KAHN DJ MOSS TJ DAVIS JM HUELSKAMP AM NOGA SJ DAVIDSON NE KENNEDY MJ
Citation: Jl. Passoscoelho et al., SIMILAR BREAST-CANCER CELL CONTAMINATION OF SINGLE-DAY PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS OBTAINED AFTER PRIMING WITH HEMATOPOIETIC GROWTH-FACTOR ALONE OR AFTER CYCLOPHOSPHAMIDE FOLLOWED BY GROWTH-FACTOR, Journal of clinical oncology, 14(9), 1996, pp. 2569-2575
CELL CYCLE-SPECIFIC BEHAVIOR OF ERYTHROPOIETIN
Authors: SPIVAK JL FERRIS DK FISHER J NOGA SJ ISAACS M CONNOR E HANKINS WD
Citation: Jl. Spivak et al., CELL CYCLE-SPECIFIC BEHAVIOR OF ERYTHROPOIETIN, Experimental hematology, 24(2), 1996, pp. 141-150
IMPROVED DETECTION OF TUMOR-CELLS BY CD45 ENRICHMENT FOLLOWED BY IMMUNOCYTOCHEMICAL (ICC) DETECTION IN BREAST-CANCER PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION (ABMT)
Authors: NOGA SJ KENNEDY MJ VALONE F ARMSTRONG D VANVLASSELAER P MOSS TJ
Citation: Sj. Noga et al., IMPROVED DETECTION OF TUMOR-CELLS BY CD45 ENRICHMENT FOLLOWED BY IMMUNOCYTOCHEMICAL (ICC) DETECTION IN BREAST-CANCER PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION (ABMT), Blood, 88(10), 1996, pp. 3651-3651
GENERATION EXPANSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-CELLS (CTLS) IN GAS-PERMEABLE CELL-CULTURE BAGS/
Authors: DAVIS JM ORENTAS R EBY LL FLINN I LEMAS MV NOGA SJ AMBINDER RF
Citation: Jm. Davis et al., GENERATION EXPANSION OF EPSTEIN-BARR-VIRUS (EBV)-SPECIFIC CYTOTOXIC T-CELLS (CTLS) IN GAS-PERMEABLE CELL-CULTURE BAGS/, Blood, 88(10), 1996, pp. 434-434
COMPARISON OF MONONUCLEAR-CELLS (MNC) SEPARATED FROM BONE-MARROW (BM)USING LYMPHOCYTE SEPARATION MEDIA (LSM) AND A PHYSIOLOGICAL DENSITY GRADIENT MEDIUM, CELLSEP(TM)
Authors: TURNER CE DAVIS JM SCHEPERS KG EBY LL SCHOTT BA NOGA SJ
Citation: Ce. Turner et al., COMPARISON OF MONONUCLEAR-CELLS (MNC) SEPARATED FROM BONE-MARROW (BM)USING LYMPHOCYTE SEPARATION MEDIA (LSM) AND A PHYSIOLOGICAL DENSITY GRADIENT MEDIUM, CELLSEP(TM), Blood, 88(10), 1996, pp. 1019-1019
DONOR LEUKOCYTE INFUSIONS (DLI) FOR THE TREATMENT OF RELAPSED HEMATOLOGICAL MALIGNANCIES AFTER ALLOGENEIC ELUTRIATED BONE-MARROW TRANSPLANTATION (BMT)
Authors: SEBER A NOGA SJ HARRIS D HATTENBURG C FUCHS EJ
Citation: A. Seber et al., DONOR LEUKOCYTE INFUSIONS (DLI) FOR THE TREATMENT OF RELAPSED HEMATOLOGICAL MALIGNANCIES AFTER ALLOGENEIC ELUTRIATED BONE-MARROW TRANSPLANTATION (BMT), Blood, 88(10), 1996, pp. 1030-1030
FEASIBILITY OF DONOR LEUKOCYTE (DL) STORAGE
Authors: SCHOTT BA DAVIS JM HARRIS DP SCHEPERS KG EBY LL TURNER CE NOGA SJ
Citation: Ba. Schott et al., FEASIBILITY OF DONOR LEUKOCYTE (DL) STORAGE, Blood, 88(10), 1996, pp. 1632-1632
DO INDIVIDUAL GRAFT PARAMETERS INFLUENCE ENGRAFTMENT OR GVHD IN PATIENTS RECEIVING ELUTRIATED CD34+ AUGMENTED ALLOGRAFTS/
Authors: ODONNELL PV NOGA SJ VOGELSANG GB SEBER A SCHEPERS K DAVIS JM JONES RJ
Citation: Pv. Odonnell et al., DO INDIVIDUAL GRAFT PARAMETERS INFLUENCE ENGRAFTMENT OR GVHD IN PATIENTS RECEIVING ELUTRIATED CD34+ AUGMENTED ALLOGRAFTS/, Blood, 88(10), 1996, pp. 1670-1670
TUMOR-CELLS FREQUENTLY DETECTED IN MARROW AND MOBILIZED BLOOD HEMATOPOIETIC GRAFTS IN NEUROBLASTOMA AND PRIMITIVE NEUROECTODERMAL TUMOR - PURGING BY IMMUNOMAGNETIC CD34+ CELL SELECTION
Authors: LEUNG W CHEN AR KLANN RC MOSS TJ DAVIS JE NOGA SJ KENT HW CONWAY JM COHEN KJ FRIEDMAN AD SMALL D SCHWARTZ CL CIVIN CI
Citation: W. Leung et al., TUMOR-CELLS FREQUENTLY DETECTED IN MARROW AND MOBILIZED BLOOD HEMATOPOIETIC GRAFTS IN NEUROBLASTOMA AND PRIMITIVE NEUROECTODERMAL TUMOR - PURGING BY IMMUNOMAGNETIC CD34+ CELL SELECTION, Blood, 88(10), 1996, pp. 1917-1917
QUANTITATIVE ASSESSMENT OF MYELOMA PERIPHERAL-BLOOD AND BONE-MARROW TUMOR BURDEN IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION
Authors: VESCIO RA SCHILLER GJ STEWART AK ANDERSON KC DIPERSIO JF NOGA SJ BALLESTER OF RUGO H FREYTES CO WU CH HAN EJ CAO J BELSON DJ BERENSON JR
Citation: Ra. Vescio et al., QUANTITATIVE ASSESSMENT OF MYELOMA PERIPHERAL-BLOOD AND BONE-MARROW TUMOR BURDEN IN PATIENTS UNDERGOING AUTOLOGOUS TRANSPLANTATION, Blood, 88(10), 1996, pp. 2551-2551
PREDICTIVE FACTORS FOR PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS USING A SINGLE LARGE-VOLUME LEUKAPHERESIS AFTER CYCLOPHOSPHAMIDE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR MOBILIZATION
Authors: PASSOSCOELHO JL BRAINE HG DAVIS JM HUELSKAMP AM SCHEPERS KG OHLY K CLARKE B WRIGHT SK NOGA SJ DAVIDSON NE KENNEDY MJ
Citation: Jl. Passoscoelho et al., PREDICTIVE FACTORS FOR PERIPHERAL-BLOOD PROGENITOR-CELL COLLECTIONS USING A SINGLE LARGE-VOLUME LEUKAPHERESIS AFTER CYCLOPHOSPHAMIDE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR MOBILIZATION, Journal of clinical oncology, 13(3), 1995, pp. 705-714
TRANSIENT LEUKOCYTE SLUMP - A COMMON OCCURRENCE AFTER ALLOGENEIC BMT
Authors: SEBER A ZAHURAK ML NOGA SJ JONES RJ GOODMAN SN VOGELSANG GB
Citation: A. Seber et al., TRANSIENT LEUKOCYTE SLUMP - A COMMON OCCURRENCE AFTER ALLOGENEIC BMT, Blood, 86(10), 1995, pp. 395-395
GRAFT ENGINEERING .5. ISOLATION, CRYOPRESERVATION, AND ACTIVATION OF CD56(-MARROW() CELLS RECOVERED AFTER CD34(+) SELECTION OF ELUTRIATED BONE)
Authors: TURNER CE DAVIS JM HARRIS DP SCHEPERS KG EBY LL NOGA SJ
Citation: Ce. Turner et al., GRAFT ENGINEERING .5. ISOLATION, CRYOPRESERVATION, AND ACTIVATION OF CD56(-MARROW() CELLS RECOVERED AFTER CD34(+) SELECTION OF ELUTRIATED BONE), Blood, 86(10), 1995, pp. 456-456
THE INCIDENCE OF GVHD, BUT NOT ENGRAFTMENT IS AFFECTED BY CYCLOSPORINE-A (CSA) DURATION FOLLOWING TRANSPLANTATION WITH CD34+ AUGMENTED ELUTRIATED (A/E) MARROW/
Authors: NOGA SJ VOGELSANG GB SEBER A CHEN AR JONES RJ
Citation: Sj. Noga et al., THE INCIDENCE OF GVHD, BUT NOT ENGRAFTMENT IS AFFECTED BY CYCLOSPORINE-A (CSA) DURATION FOLLOWING TRANSPLANTATION WITH CD34+ AUGMENTED ELUTRIATED (A/E) MARROW/, Blood, 86(10), 1995, pp. 1566-1566
HETEROGENEOUS MOBILIZATION OF CD34-CELLS FOR AUTOLOGOUS RESCUE OF CHILDREN WITH POOR-PROGNOSIS SOLID TUMORS( BLOOD STEM)
Authors: CHEN AR COHEN KJ EBY LL DAVIS JM NOGA SJ BOROWITZ MJ BRAINE HG KENT HW CONWAY JM CIVIN CI
Citation: Ar. Chen et al., HETEROGENEOUS MOBILIZATION OF CD34-CELLS FOR AUTOLOGOUS RESCUE OF CHILDREN WITH POOR-PROGNOSIS SOLID TUMORS( BLOOD STEM), Blood, 86(10), 1995, pp. 1598-1598
LOW-RISK OF EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) IN PATIENTS RECEIVING ELUTRIATED ALLOGENEIC MARROW TRANSPLANTS MAY REFLECT DEPLETION OF EBV INFECTED LYMPHOCYTES FROM THE GRAFT
Authors: FLINN I ORENTAS R NOGA SJ MARCELLUS D VOGELSAND GB JONES RJ AMBINDER RF
Citation: I. Flinn et al., LOW-RISK OF EPSTEIN-BARR-VIRUS (EBV)-ASSOCIATED POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE (PTLD) IN PATIENTS RECEIVING ELUTRIATED ALLOGENEIC MARROW TRANSPLANTS MAY REFLECT DEPLETION OF EBV INFECTED LYMPHOCYTES FROM THE GRAFT, Blood, 86(10), 1995, pp. 2490-2490
Risultati: 1-25 | 26-38